On September 17–20, 2016 the regular 15th congress of the Federation of Anesthesiologists and Critical Care Physicians was held in Moscow, the Enterprise took part in a number of events.
The FSUE Moscow Endocrine Plant has a full line of its own domestic drugs necessary for the direct medical activities of this category of specialists. During the 4 days of the congress, the employees of the Enterprise familiarized the representatives of the medical community with the drugs produced by the FSUE Moscow Endocrine Plant, which are used in anesthesiology, critical care medicine and oncology.
On September 19, the off-site symposium was held at the Enterprise which participants were anesthetists and critical care physicians from different regions of the Russian Federation. The purpose of this event was to familiarize doctors with the product line of FSUE Moscow Endocrine Plant.
During the presentation of the Enterprise at the exhibition site and during the off-site event the FSUE Moscow Endocrine Plant provided information on the current line of drugs and on registered drugs. They include the drug Tramadol 50 mg capsules, the start of sales of which is scheduled for October 2016, the drugs Midazolam solution for intravenous and intramuscular administration, BUPRAXON® sublingual tablets registered in 2016, the start of sales is 2017.
In turn the doctors addressed with a number of wishes and suggestions regarding the introduction of new drugs.
Such a dialogue is recognized as an effective form of interaction between the drug manufacturing company and the medical community. Carrying out of events of this format is planned in future.
Comment type is not specified in the component properties.